skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study

Original Research

(4924) Views  (1434) Full article downloads

Authors: Gian Galeazzo Riario-Sforza, Cristoforo Incorvaia, Fulvia Paterniti, et al

Published Date August 2009 Volume 2009:4 Pages 315 - 319
DOI: http://dx.doi.org/10.2147/COPD.S5905

Gian Galeazzo Riario-Sforza1, Cristoforo Incorvaia1, Fulvia Paterniti1, Laura Pessina1, Roberta Caligiuri1, Chiara Pravettoni1, Fabiano Di Marco2, Stefano Centanni2

1Pulmonary Rehabilitation, Istituti Clinici di Perfezionamento, Milan, Italy; 2Unit of Respiratory Medicine, University of Milan, San Paolo Hospital, Milan, Italy

Background: Pulmonary rehabilitation (PR) is recognized as an evidence-based treatment in improving dyspnea and quality of life in patients with COPD. We evaluated the number needed to treat (NNT) to achieve an increase in physical capacity, as defined by a significant improvement in the six-minute walk test (6MWT) in patients with COPD undergoing PR.

Methods: The study enrolled 284 patients aged 41 to 86 years (mean age 69.4 years) divided into two groups: a study group (222 patients) undergoing a PR program, and a control group (62 patients) treated only with drugs. The study group included patients with COPD divided in four subgroups according to GOLD stages.

Results: In the study group, 142 out of 222 patients (64%) had an increase of at least 54 m in the 6MWT following PR versus 8 out of 62 patients (13%) in the control group after the same time interval. The NNT in the overall study group was 2; the same NNT was obtained in GOLD stages 2, 3, and 4, but was 8 in stage 1.

Conclusions: PR is highly effective in improving the exercise capacity of patients with COPD, as demonstrated by a valuable NNT, with better results in patients with a more severe disease.

Keywords: chronic obstructive lung disease, exercise capacity, number needed to treat, pulmonary rehabilitation, six-minute walk test






 

Other articles by Dr Cristoforo Incorvaia

Adherence issues related to sublingual immunotherapy as perceived by allergists
Development of a sublingual allergy vaccine for grass pollinosis
Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation
Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio